Dexamethasone is a potent synthetic glucocorticoid with minimal mineralocorticoid activity, used across an exceptionally wide range of indications from anti-inflammatory and immunosuppressant therapy to cerebral oedema, nausea prophylaxis and, in low-dose, life-saving reduction of COVID-19 mortality in hospitalised patients. Simson Pharma's Dexamethasone reference standard and impurities support the broad compendial testing this versatile corticosteroid demands.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Dexamethasone Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.